Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

hydroxychloroquine

hydroxychloroquine
  • Restricted Indications other than COVID-19
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Plaquenil, Quineprox TABLET, ORAL 200 mg      
VIEW MORE Antimalarials
CLASS
083008
Comments:

Formulary, Restricted to indications other than COVID-19 or continuation of home medications. Pharmacists should contact providers for alternative COVID-19 therapies.

Pharmacist-led EKG monitoring program discontinued (Jan 2023)

Updated: March 20, 2020 (COVID-19), 24 March 2020 (COVID-19). 28 April 2020 (COVID-19), Jan 2023 (COVID-19 indications removed)

Last updated: Feb. 1, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved